All stock lists
Legacy Housing Corp (NASDAQ:LEGH)
US · Delayed Price · Currency is USD
Consumer Cyclical · Residential Construction
28.26+0.22 (+0.78%)
Market cap
$672M
Health Score
Analyst consensus
Listed since
Dec 14, 2018
Website
Insider Score
––Not scored
LEGH Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Strong
From LEGH’s reported statements · Q2 2026 (trailing 12 months)
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $179.4M
- Net income
- $51.2M
- Net margin
- 28.6%
Leverage20 / 20
Little or no net debt.
- Total debt
- $1.1M
- Cash
- $29.0M
- Net debt / EBITDA
- -0.44x
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $181.2M
- Current liabilities
- $51.0M
- Current ratio
- 3.56
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $50.6M
- Free cash flow
- $38.6M
- FCF margin
- 21.5%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 23.8M
- Share growth (1y)
- -1.1%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
LEGH Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 66.35 M | 34.37 M | 38.26 M | 40.48 M | 50.16 M | 35.67 M |
| Revenue Growth (YoY) | 32.27 % | -3.66 % | -29.40 % | -8.56 % | 18.04 % | -17.51 % |
| Cost of Revenue | 33.52 M | 14.94 M | 18.73 M | 23.54 M | 26.57 M | 17.19 M |
| Gross Profit | 32.83 M | 19.43 M | 19.52 M | 16.93 M | 23.59 M | 18.48 M |
| SG&A Expense | 6.91 M | 5.84 M | 9.23 M | 7.23 M | 6.78 M | 6.30 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 6.37 M | 7.04 M | 9.23 M | 7.23 M | 6.78 M | 6.89 M |
| Operating Income | 26.46 M | 12.39 M | 10.29 M | 9.71 M | 16.82 M | 11.59 M |
| Pretax Income | 26.45 M | 13.02 M | 10.80 M | 10.26 M | 17.78 M | 12.73 M |
| Tax Provision | 2.96 M | 2.10 M | 2.61 M | 1.61 M | 3.08 M | 2.45 M |
| Net Income | 23.48 M | 10.93 M | 8.19 M | 8.64 M | 14.70 M | 10.28 M |
| EPS (Basic) | 0.99 | 0.46 | 0.34 | 0.36 | 0.61 | 0.43 |
| EPS (Diluted) | 0.99 | 0.46 | 0.34 | 0.35 | 0.60 | 0.41 |
| Shares Outstanding | 23.78 M | 23.81 M | 23.83 M | 23.87 M | 24.05 M | 24.13 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
